Addressing antimicrobial resistance in Nigerian hospitals: exploring physicians prescribing behavior, knowledge, and perception of antimicrobial resistance and stewardship programs.

Abstract:

INTRODUCTION:We assessed the knowledge of, attitude toward antimicrobial resistance (AMR) and practice of antimicrobial stewardship (AMS) among physicians in Nigeria to provide future guidance to the Nigerian National Action Plan for AMR. METHODS:A descriptive cross-sectional questionnaire-based study explored the physicians' self-reported practice of antibiotic prescribing, knowledge, attitude, and practice of AMR and components of ASPs. RESULTS:The majority (217; 67.2%) of respondents prescribed antibiotics daily in their clinical practice AMR was recognized as a global and local problem by 308 (95.4%) and 262 (81.1%) respondents, respectively. Only 91 (28.2%) of respondents have ever heard of antibiotic stewardship. The median AMR knowledge score was 40 (19-45)out of 45while that for ASP was 46.0(32-57) out of 60. There was significant statistical difference between the ASP median scores among the medical specialties category (P value <0.0001) More respondents had good knowledge of AMR than ASPs (82.7% versus 36.5%; p < 0.0001). CONCLUSION:Respondents in this study were more knowledgeable about AMR than AMS and its core components.

authors

Babatola AO,Fadare JO,Olatunya OS,Obiako R,Enwere O,Kalungia A,Ojo TO,Sunmonu TA,Desalu O,Godman B

doi

10.1080/14787210.2021.1829474

subject

Has Abstract

pub_date

2020-11-02 00:00:00

pages

1-10

eissn

1478-7210

issn

1744-8336

pub_type

杂志文章
  • Treatment of invasive candidiasis: between guidelines and daily clinical practice.

    abstract::Invasive candidiasis, including candidemia (IC/C), is a major cause of morbidity and mortality among hospitalized patients. While incidence is higher in intensive care units, the majority of cases of candidemia are documented in medical wards. Although Candida albicans is still the most frequently isolated species, IC...

    journal_title:Expert review of anti-infective therapy

    pub_type: 社论

    doi:10.1586/14787210.2015.1029916

    authors: Tagliaferri E,Menichetti F

    更新日期:2015-06-01 00:00:00

  • HIV and malaria interactions: where do we stand?

    abstract::Reversing the spread of HIV infection and the incidence of malaria constitute two of the Millenium Development Goals. However, despite recent achievements, both diseases still entail global heath problems. Furthermore, their overlapping geographical distribution raises concerns and challenges for potential immunologic...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.11.167

    authors: González R,Ataíde R,Naniche D,Menéndez C,Mayor A

    更新日期:2012-02-01 00:00:00

  • Is it time to revisit routine administration of antibiotic for preterm prelabor rupture of membranes?

    abstract::Preterm prelabor rupture of membranes (pPROM) is the precursor of up to 40% of preterm deliveries and an independent risk factor for neonatal disease, death and long-term pulmonary and neurodevelopmental deficits. A significant proportion of cases of pPROM are infection driven, although these are difficult to delineat...

    journal_title:Expert review of anti-infective therapy

    pub_type: 评论,杂志文章

    doi:10.1586/14787210.5.4.551

    authors: Ugwumadu A

    更新日期:2007-08-01 00:00:00

  • Hepatitis C infection of B lymphocytes: more tools to address pending questions.

    abstract::Hepatitis C virus (HCV) infection spreads primarily via contact with infected blood and can establish a persistent infection in 80% of infected individuals, progressively causing chronic liver disease that can lead to hepatocellular carcinoma or end-stage liver disease requiring a transplant. There is no vaccine, and ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 评论,杂志文章

    doi:10.1586/eri.10.86

    authors: Stamataki Z

    更新日期:2010-09-01 00:00:00

  • Prevention of influenza in healthy children.

    abstract::Healthy children are high transmitters of influenza and can experience poor influenza outcomes. Many questions remain about the efficacy and impect of preventive measures because most existing studies report imprecise proxies of influenza incidence, do not follow subjects throughout the entire influenza season and acr...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.12.106

    authors: Lee BY,Shah M

    更新日期:2012-10-01 00:00:00

  • A clear and present danger: tick-borne diseases in Europe.

    abstract::Ticks can transmit a variety of viruses, bacteria or parasites that can cause serious infections or conditions in humans and animals. While tick-borne diseases are becoming an increasing and serious problem in Europe, tick-borne diseases are also responsible for major depressions in livestock production and mortality ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.09.118

    authors: Heyman P,Cochez C,Hofhuis A,van der Giessen J,Sprong H,Porter SR,Losson B,Saegerman C,Donoso-Mantke O,Niedrig M,Papa A

    更新日期:2010-01-01 00:00:00

  • 2010 HIV Diagnostics Conference.

    abstract::During the 2010 HIV Diagnostics Conference, which took place in Orlando (FL, USA) between 24 and 26 March 2010, salient new data related to three aspects of HIV testing (rapid point-of-care testing, laboratory assays and new technologies) were presented and discussed. A conundrum central to HIV diagnostics in the USA ...

    journal_title:Expert review of anti-infective therapy

    pub_type:

    doi:10.1586/eri.10.48

    authors: Pandori MW,Branson BM

    更新日期:2010-06-01 00:00:00

  • Clinical and economic burden of antimicrobial resistance.

    abstract::Knowledge of the clinical and economic impact of antimicrobial resistance is useful to influence programs and behavior in healthcare facilities, to guide policy makers and funding agencies, to define the prognosis of individual patients and to stimulate interest in developing new antimicrobial agents and therapies. Th...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.6.5.751

    authors: Maragakis LL,Perencevich EN,Cosgrove SE

    更新日期:2008-10-01 00:00:00

  • Influenza infection in human host: challenges in making a better influenza vaccine.

    abstract::Influenza is a ubiquitous infection with a spectrum ranging from mild to severe. The mystery regarding such variability in the clinical spectrum has not been fully unravelled, although a role for the complex interplay among virus characteristics, host immune response and environmental factors has been suggested. Antiv...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2016.1155450

    authors: Virk RK,Gunalan V,Tambyah PA

    更新日期:2016-01-01 00:00:00

  • HIV/AIDS pathogenesis and treatment options focusing on the viral entry inhibitors.

    abstract::The advent of highly active antiretroviral therapy (HAART) has revolutionized the treatment of HIV. A wide variety of antiretroviral agents are now available, allowing patients and physicians a choice of effective therapy. However, drug resistance and toxicities are emerging as major treatment challenges in the HAART ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.4.2.303

    authors: Jones R,Gazzard B

    更新日期:2006-04-01 00:00:00

  • Mycobacterium caprae infection in humans.

    abstract::Mycobacterium caprae, a member of the Mycobacterium tuberculosis complex, causes tuberculosis (TB) in man and animals. Some features distinguish M. caprae from its epidemiological twin, Mycobacterium bovis: M. caprae is evolutionarily older, accounts for a smaller burden of zoonotic TB and is not globally distributed,...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2014.974560

    authors: Prodinger WM,Indra A,Koksalan OK,Kilicaslan Z,Richter E

    更新日期:2014-12-01 00:00:00

  • Development and progression of gastroesophageal varices in patients with chronic hepatitis C.

    abstract::Hepatitis C virus infection is the leading cause of chronic liver disease in the western world. Chronic liver diseases may cause, through portal hypertension, the development of gastroesophageal varices, which can then bleed. We assess the findings of a study aimed at identifying the incidence of de novo varix develop...

    journal_title:Expert review of anti-infective therapy

    pub_type: 评论,杂志文章

    doi:10.1586/eri.10.71

    authors: Gentile I,Borgia G

    更新日期:2010-08-01 00:00:00

  • Tocilizumab for patients with severe COVID-19: a retrospective, multi-center study.

    abstract:BACKGROUND:Tocilizumab, an inhibitor of the interleukin-6 receptor, may decrease the inflammatory response and control the symptoms of severe coronavirus disease 2019 (COVID-19), but the evidence is scarce. METHODS:This retrospective study included patients with severe COVID-19 requiring oxygen therapy who received to...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,多中心研究

    doi:10.1080/14787210.2020.1800453

    authors: Tomasiewicz K,Piekarska A,Stempkowska-Rejek J,Serafińska S,Gawkowska A,Parczewski M,Niścigorska-Olsen J,Łapiński TW,Zarębska-Michaluk D,Kowalska JD,Horban A,Flisiak R

    更新日期:2021-01-01 00:00:00

  • Lymphogranuloma venereum among men who have sex with men. An epidemiological and clinical review.

    abstract::Lymphogranuloma venereum (LGV) is a sexually transmitted infection, previously only seen in tropical regions. This changed in 2003 when the first endemically acquired LGV cases were reported in Rotterdam, the Netherlands, among predominantly HIV positive men who have sex with men (MSM). Early diagnosis is important to...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2014.901169

    authors: de Vrieze NH,de Vries HJ

    更新日期:2014-06-01 00:00:00

  • HIV-1/hepatitis B coinfection.

    abstract::Reviews the epidemiology, natural history and the current status of treatment of HIV/hepatitis B coinfection. ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.3.2.229

    authors: Benhamou Y

    更新日期:2005-04-01 00:00:00

  • MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale.

    abstract:INTRODUCTION:COVID-19 disease progresses through a number of distinct phases. The management of each phase is unique and specific. The pulmonary phase of COVID-19 is characterized by an organizing pneumonia with profound immune dysregulation, activation of clotting, and a severe microvascular injury culminating in seve...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章

    doi:10.1080/14787210.2020.1808462

    authors: Marik PE,Kory P,Varon J,Iglesias J,Meduri GU

    更新日期:2020-08-18 00:00:00

  • Immune approaches in tuberculosis therapy: a brief overview.

    abstract::TB is typically caused by Mycobacterium tuberculosis, a symbiotic bacterium present in one-third of the world's population. There any many factors triggering overt clinical disease in a small proportion of humans. In our view the major role in the process is played by the host's immune response, especially self-direct...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.12.1

    authors: Bourinbaiar AS,Mezentseva MV,Butov DA,Nyasulu PS,Efremenko YV,Jirathitikal V,Mishchenko VV,Kutsyna GA

    更新日期:2012-03-01 00:00:00

  • Sepsis-associated encephalopathy and septic encephalitis: an update.

    abstract:INTRODUCTION:Sepsis-associated encephalopathy (SAE) and septic encephalitis (SE) are associated with increased mortality, long-term cognitive impairment, and focal neurological deficits. AREAS COVERED:The PUBMED database was searched 2016-2020. The clinical manifestation of SAE is delirium, SE additionally is characte...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章

    doi:10.1080/14787210.2020.1812384

    authors: Tauber SC,Djukic M,Gossner J,Eiffert H,Brück W,Nau R

    更新日期:2020-09-14 00:00:00

  • Molecular tools for rapid identification and novel effective therapy against MDRTB/XDRTB infections.

    abstract::Tuberculosis (TB) is mainly an intracellular infection of the lung alveolar macrophages, and any anti-TB agent must therefore be active at the macrophage. Among the available therapies, isoniazid and rifampicin are the most effective drugs against susceptible Mycobacterium tuberculosis, but they are ineffective agains...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.10.20

    authors: Viveiros M,Martins M,Couto I,Rodrigues L,Machado D,Portugal I,Amaral L

    更新日期:2010-04-01 00:00:00

  • Biological challenges of phage therapy and proposed solutions: a literature review.

    abstract::Introduction: In light of the emergence of antibiotic-resistant bacteria, phage (bacteriophage) therapy has been recognized as a potential alternative or addition to antibiotics in Western medicine for use in humans.Areas covered: This review assessed the scientific literature on phage therapy published between 1 Janu...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2019.1694905

    authors: Caflisch KM,Suh GA,Patel R

    更新日期:2019-12-01 00:00:00

  • Treatment options for multidrug-resistant bacteria.

    abstract::As a consequence of antibiotic overuse and misuse, nosocomial infections caused by multidrug-resistant bacteria represent a physician's nightmare throughout the world. No newer antimicrobials active against Pseudomonas aeruginosa, the main multidrug-resistant nosocomial pathogen, are available or under investigation. ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.4.4.601

    authors: Giamarellou H

    更新日期:2006-08-01 00:00:00

  • Telaprevir for the treatment of chronic hepatitis C infection.

    abstract::Telaprevir is an NS3/4A protease inhibitor that has recently received US FDA approval for the treatment of chronic HCV infection. Telaprevir is given in combination with peg-IFN-α and ribavirin and is indicated for both treatment-naive and treatment-experienced patients with genotype 1 infection. Along with the other ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.11.133

    authors: Muir AJ

    更新日期:2011-12-01 00:00:00

  • Rapid molecular diagnostics for multi-drug resistant tuberculosis in India.

    abstract:INTRODUCTION:Rapid molecular diagnostic methods help in the detection of TB and Rifampicin resistance. These methods detect TB early, are accurate and play a crucial role in reducing the burden of drug resistant tuberculosis. Areas covered: This review analyses rapid molecular diagnostic tools used in the diagnosis of ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2018.1438262

    authors: Ramachandran R,Muniyandi M

    更新日期:2018-03-01 00:00:00

  • Clinical management of women with listeriosis risk during pregnancy: a review of national guidelines.

    abstract:INTRODUCTION:Listeriosis is an uncommon foodborne infection that may cause moderate maternal illness, but can be extremely serious for the fetus and the newborn. Several guidelines have been elaborated in order to help clinicians on the care of pregnant women with known or suspected exposure to Listeria monocytogenes. ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2018.1417837

    authors: Pucci L,Massacesi M,Liuzzi G

    更新日期:2018-01-01 00:00:00

  • Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs.

    abstract:INTRODUCTION:Latent tuberculosis infection (LTBI) accounts for almost a quarter of the world population, and, in 5-10% of the subjects with impaired immune-response against M. tuberculosis growth, it may progress to active tuberculosis (TB). In this review, we focus on the need to propose a screening for LTBI including...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2018.1483238

    authors: Goletti D,Petrone L,Ippolito G,Niccoli L,Nannini C,Cantini F

    更新日期:2018-06-01 00:00:00

  • Invasive pulmonary aspergillosis.

    abstract::In susceptible patients, invasive aspergillosis has a high incidence and a mortality of up to 80%. The diagnosis of this condition is difficult, especially in the early stages of the disease and, as a consequence, antifungal therapy, despite its expense and toxicity, is often initiated empirically. Until recently, the...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.3.4.613

    authors: Doffman SR,Agrawal SG,Brown JS

    更新日期:2005-08-01 00:00:00

  • Efavirenz-based antiretroviral therapy versus nevirapine-including regimens for prevention of mother-to-child transmission of HIV option B plus in resource-limited settings: is there anything missing?

    abstract::In 2013, an estimated 1.5 million HIV-positive pregnant women gave birth, with 240,000 children worldwide acquiring HIV. More than 90% of new pediatric infections occurred in Sub-Saharan Africa. The latest WHO guidelines recommended efavirenz (EFV)-based antiretroviral therapy as the first-line regimen for prevention ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2016.1116383

    authors: De Nardo P,Gentilotti E,Nguhuni B,Vairo F,Chaula Z,Nicastri E,Ippolito G

    更新日期:2016-01-01 00:00:00

  • Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.

    abstract:INTRODUCTION:Pneumocystis pneumonia is a potentially life-threatening pulmonary infection that occurs in immunocompromised individuals and HIV-infected patients with a low CD4 cell count. Trimethoprim-sulfamethoxazole has been used as the first-line agent for treatment, but mutations within dihydropteroate synthase gen...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2017.1364991

    authors: Huang YS,Yang JJ,Lee NY,Chen GJ,Ko WC,Sun HY,Hung CC

    更新日期:2017-09-01 00:00:00

  • Diagnostic accuracy of the Xpert MTB/RIF assay for abdominal tuberculosis: a systematic review and meta-analysis.

    abstract:BACKGROUND:We performed a meta-analysis to determine diagnostic accuracy of Xpert MTB/RIF for diagnosis of abdominal (intestinal or peritoneal) tuberculosis (TB) in various tissues (intestinal, omental/peritoneal tissue or ascitic fluid). METHODS:Electronic databases were searched for observational studies on use of X...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章

    doi:10.1080/14787210.2020.1816169

    authors: Sharma V,Soni H,Kumar-M P,Dawra S,Mishra S,Mandavdhare HS,Singh H,Dutta U

    更新日期:2020-08-26 00:00:00

  • Does lopinavir/ritonavir alter the primary gingival epithelium?

    abstract::In clinical practice, a significant proportion of HIV-infected patients receive lopinavir/ritonavir (LPV/r) as a component of highly active antiretroviral therapy (HAART). The study by Israr et al. was designed to evaluate the effects of the HIV protease inhibitor LPV/r on gingival epithelium growth and differentiatio...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章

    doi:10.1586/eri.10.138

    authors: Rivero A,Pérez-Camacho I

    更新日期:2010-12-01 00:00:00